Myfortic (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Myfortic drug offered from Avera McKennan Hospital. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | mycophenolic acid |
| SUBSTANCE NAME: | MYCOPHENOLATE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-03-01 |
| END MARKETING DATE: | 0000-00-00 |
Myfortic HUMAN PRESCRIPTION DRUG Details:
| Item Description | Myfortic from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 180(mg/1) |
| START MARKETING DATE: | 2015-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-0385_357a6afc-99d8-4fc9-bfd8-ad634a042999 |
| PRODUCT NDC: | 69189-0385 |
| APPLICATION NUMBER: | NDA050791 |
Other MYCOPHENOLATE SODIUM Pharmaceutical Manufacturers / Labelers:
